BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22715915)

  • 1. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
    BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
    Husaiyin S; Han L; Mamat H; Husaiyin K; Wang L; Niyazi M
    Jpn J Infect Dis; 2016 Jul; 69(4):273-8. PubMed ID: 26255734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
    Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
    Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
    Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
    J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
    Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia.
    Bedoya AM; Gaviria AM; Baena A; Borrero M; Duarte DF; Combita AL; Castaño J; Grisales H; Sánchez GI
    Int J Gynecol Cancer; 2012 Feb; 22(2):303-10. PubMed ID: 22228426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, Brazil.
    Rama CH; Villa LL; Pagliusi S; Andreoli MA; Costa MC; Thomann P; Longatto-Filho A; Eluf-Neto J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1405-10. PubMed ID: 21051985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial.
    Wei LH; Su YY; Hu YM; Li RC; Chen W; Pan QJ; Zhang X; Zhao FH; Zhao YQ; Li Q; Hong Y; Zhao C; Li MQ; Liu WY; Li CH; Guo DP; Ke LD; Lin BZ; Lin ZJ; Chen S; Sheng W; Zheng ZZ; Zhuang SJ; Zhu FC; Pan HR; Li YM; Huang SJ; Zhang J; Qiao YL; Wu T; Xia NS
    Clin Microbiol Infect; 2020 Aug; 26(8):1069-1075. PubMed ID: 31904566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
    Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
    Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
    Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
    Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
    Velentzis LS; Sitas F; O'Connell DL; Darlington-Brown J; Egger S; Sinha R; Banks E; Frazer IH; Canfell K
    BMC Infect Dis; 2014 Dec; 14():3861. PubMed ID: 25528152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
    Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
    Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.
    Introcaso CE; Dunne EF; Hariri S; Panicker G; Unger ER; Markowitz LE
    Sex Transm Infect; 2014 Sep; 90(6):505-8. PubMed ID: 24748563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific HPV seroprevalence among young females in The Netherlands.
    Kramer M; Mollema L; Smits G; Boot H; de Melker H; van der Klis F
    Sex Transm Infect; 2010 Dec; 86(7):494-9. PubMed ID: 20519252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of seropositivity among HPV-16/18 DNA positive young women.
    Porras C; Bennett C; Safaeian M; Coseo S; Rodríguez AC; González P; Hutchinson M; Jiménez S; Sherman ME; Wacholder S; Solomon D; van Doorn LJ; Bougelet C; Quint W; Schiffman M; Herrero R; Hildesheim A;
    BMC Infect Dis; 2010 Aug; 10():238. PubMed ID: 20698998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.